136 related articles for article (PubMed ID: 11988148)
1. [Treatment perspectives: immunotherapy with latex].
Tabar AI; Anda M; Gómez B; García B; Lizaso MT; Echechipía S; Arroabarren E; Olaguibel JM
Allergol Immunopathol (Madr); 2002; 30(3):163-70. PubMed ID: 11988148
[TBL] [Abstract][Full Text] [Related]
2. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers.
Leynadier F; Herman D; Vervloet D; Andre C
J Allergy Clin Immunol; 2000 Sep; 106(3):585-90. PubMed ID: 10984382
[TBL] [Abstract][Full Text] [Related]
3. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study.
Sastre J; Fernández-Nieto M; Rico P; Martín S; Barber D; Cuesta J; de las Heras M; Quirce S
J Allergy Clin Immunol; 2003 May; 111(5):985-94. PubMed ID: 12743562
[TBL] [Abstract][Full Text] [Related]
4. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients.
Tabar AI; Anda M; Bonifazi F; Bilò MB; Leynadier F; Fuchs T; Ring J; Galvain S; André C
Int Arch Allergy Immunol; 2006; 141(4):369-76. PubMed ID: 16943675
[TBL] [Abstract][Full Text] [Related]
5. The safety of a novel sublingual rush induction phase for latex desensitization.
Nettis E; Di Leo E; Calogiuri G; Milani M; Delle Donne P; Ferrannini A; Vacca A
Curr Med Res Opin; 2010 Aug; 26(8):1855-9. PubMed ID: 20521869
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study.
Nettis E; Colanardi MC; Soccio AL; Marcandrea M; Pinto L; Ferrannini A; Tursi A; Vacca A
Br J Dermatol; 2007 Apr; 156(4):674-81. PubMed ID: 17493066
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
[TBL] [Abstract][Full Text] [Related]
8. Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract.
Cisteró Bahima A; Sastre J; Enrique E; Fernández M; Alonso R; Quirce S; Gandarias B; Parmiani S; Rico P
J Investig Allergol Clin Immunol; 2004; 14(1):17-25. PubMed ID: 15160438
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase.
Nucera E; Schiavino D; Sabato V; Colagiovanni A; Pecora V; Rizzi A; Aruanno A; Milani M; Pollastrini E; Patriarca G
Curr Med Res Opin; 2008 Apr; 24(4):1147-54. PubMed ID: 18334054
[TBL] [Abstract][Full Text] [Related]
10. [Perspectives in the treatment of allergy to latex: immunotherapy].
Tabar AI; Gómez B; Arroabarren E; Rodríguez M; Lázaro I; Anda M
An Sist Sanit Navar; 2003; 26 Suppl 2():97-102. PubMed ID: 13679968
[TBL] [Abstract][Full Text] [Related]
11. Latex sublingual immunotherapy: can its safety be predicted?
Buyukozturk S; Gelincik A; Ozşeker F; Colakoğlu B; Dal M
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):339-42. PubMed ID: 20408345
[TBL] [Abstract][Full Text] [Related]
12. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients.
Gastaminza G; Algorta J; Uriel O; Audicana MT; Fernandez E; Sanz ML; Muñoz D
Trials; 2011 Aug; 12():191. PubMed ID: 21827704
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
15. Latex immunotherapy: state of the art.
Nettis E; Delle Donne P; Di Leo E; Fantini P; Passalacqua G; Bernardini R; Canonica GW; Ferrannini A; Vacca A
Ann Allergy Asthma Immunol; 2012 Sep; 109(3):160-5. PubMed ID: 22920069
[TBL] [Abstract][Full Text] [Related]
16. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children.
Lasa Luaces EM; Tabar Purroy AI; García Figueroa BE; Anda Apiñaniz M; Sanz Laruga ML; Raulf-Heimsoth M; Barber Hernández D
Ann Allergy Asthma Immunol; 2012 May; 108(5):367-72. PubMed ID: 22541410
[TBL] [Abstract][Full Text] [Related]
17. [Failure of sublingual immunotherapy to treat latex allergy. A report of a case].
Morfin Maciel BM; Castillo Morfin BM
Rev Alerg Mex; 2008; 55(2):76-81. PubMed ID: 19058485
[TBL] [Abstract][Full Text] [Related]
18. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study.
Leynadier F; Banoun L; Dollois B; Terrier P; Epstein M; Guinnepain MT; Firon D; Traube C; Fadel R; André C
Clin Exp Allergy; 2001 Jul; 31(7):988-96. PubMed ID: 11467988
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
